Sub Cat | Application | |
---|---|---|
V3S-1124-YC1968 | WB; FC; ELISA; Block | |
V3S-0522-YC397 | ELISA; FC; Block | |
V3S-0522-YC396 | ELISA; FC |
Description | This is a recombinant human antibody that specifically targets human TIGIT. The antibody effectively binds to wild type human TIGIT with an EC₅₀ of 1.28 nM. The monoclonal antibody possesses the ability to activate T cells and natural killer cells significantly by preventing the interaction between TIGIT and CD 155. They have potential applications in cancer treatment, infectious disease treatment, and other areas. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | Human |
Isotype | IgG1, kappa |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | WB; FC; ELISA; Block |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | TIGIT |
Alternative Name | T Cell Immunoreceptor With Ig And ITIM Domains; V-Set And Immunoglobulin Domain-Containing Protein 9; V-Set And Transmembrane Domain-Containing Protein 3; T-Cell Immunoreceptor With Ig And ITIM Domains; VSIG9, VSTM3; VSIG9 |
Gene ID | 201633 |
UniProt | Q495A1 |
Research Area | Immunology |